Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity.

about

Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity.

Item

http://www.wikidata.org/entity/Q50333509

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Elevated Serum Interleukin-34 ...... ociated with Disease Activity.

@en

Elevated Serum Interleukin-34 ...... ociated with Disease Activity.

@nl

type

Item

label

Elevated Serum Interleukin-34 ...... ociated with Disease Activity.

@en

Elevated Serum Interleukin-34 ...... ociated with Disease Activity.

@nl

prefLabel

Elevated Serum Interleukin-34 ...... ociated with Disease Activity.

@en

Elevated Serum Interleukin-34 ...... ociated with Disease Activity.

@nl

P1476

Elevated Serum Interleukin-34 ...... ociated with Disease Activity.

@en

P2093

Huan Huan Xie

http://www.w3.org/2001/XMLSchema#string

Hui Shen

http://www.w3.org/2001/XMLSchema#string

Jing Lu

http://www.w3.org/2001/XMLSchema#string

Li Ping Xia

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Mei Ying Cui

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood

Discovery of a cytokine and its receptor by functional screening of the extracellular proteome

The 1982 revised criteria for the classification of systemic lupus erythematosus

The critical role of IL-34 in osteoclastogenesis

Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.

Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.

Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production.

Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis.

P304

3462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-21859-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29472590

http://www.w3.org/2001/XMLSchema#string

P932

5823931

http://www.w3.org/2001/XMLSchema#string